Overview
Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)
Status:
Completed
Completed
Trial end date:
2008-07-25
2008-07-25
Target enrollment:
0
0
Participant gender:
All
All
Summary
A study to evaluate the efficacy and safety of sitagliptin in comparison to a commonly used medication in patients with type 2 diabetesPhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Metformin
Sitagliptin Phosphate
Criteria
General Inclusion Criteria:- Patient has type 2 diabetes mellitus (T2DM)
- Patient is inadequately controlled and not on treatment with insulin or oral
antihyperglycemic therapy
General Exclusion Criteria:
- Patient has a history of type 1 diabetes mellitus or history of ketoacidosis
- Patient was on antihyperglycemic therapy (insulin or oral) within the prior 4 months